Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-19

Clinical Trial Update: Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for edaravone dexborneol in hypertensive intracerebral hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Edaravone Dexborneol

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: UNKNOWN